BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16756801)

  • 1. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
    [No Abstract]   [Full Text] [Related]  

  • 3. From left ventricular dysfunction to heart failure.
    Cleland JG
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Just the berries. Management of heart failure.
    Ruggles L
    Can Fam Physician; 2001 Mar; 47():499-501. PubMed ID: 11281082
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart failure secondary to left ventricular systolic dysfunction. Therapeutic advances and treatment recommendations.
    Dracup K
    Nurse Pract; 1996 Sep; 21(9):56-8, 61, 65-8. PubMed ID: 8884795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure: recent advances in prevention and treatment.
    Fonarow GC
    Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced heart failure.
    Jessup M; Brozena S
    Cardiol Rev; 2000; 8(3):148-57. PubMed ID: 11174888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties].
    Komajda M
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1205-7. PubMed ID: 9488765
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
    Barbour MM; Zuwallack A
    Med Health R I; 2001 Feb; 84(2):55-8. PubMed ID: 11272661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapeutic strategy in heart failure.
    Dominiak P
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S2-6. PubMed ID: 12227721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.
    J Card Fail; 1999 Dec; 5(4):357-82. PubMed ID: 10634677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():13-5. PubMed ID: 11409069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment guidelines for heart failure stress multidrug approach.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic therapy of severe heart failure].
    Kiowski W; Sütsch G; Fatio R; Schalcher C; Brunner-LaRocca HP
    Schweiz Med Wochenschr; 1997 Dec; 127(49):2026-34. PubMed ID: 9476302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
    Liu P; Arnold M; Belenkie I; Howlett J; Huckell V; Ignazewski A; LeBlanc MH; McKelvie R; Niznick J; Parker JD; Rao V; Ross H; Roy D; Smith S; Sussex B; Teo K; Tsuyuki R; White M; Beanlands D; Bernstein V; Davies R; Issac D; Johnstone D; Lee H; Moe G; Newton G; Pflugfelder P; Roth S; Rouleau J; Yusuf S;
    Can J Cardiol; 2001 Dec; 17 Suppl E():5E-25E. PubMed ID: 11773943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.